News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
321,462 Results
Type
Article (15515)
Company Profile (293)
Press Release (305653)
Multimedia
Podcasts (59)
Webinars (9)
Section
Business (92463)
Career Advice (320)
Deals (18420)
Drug Delivery (37)
Drug Development (53105)
Employer Resources (34)
FDA (6679)
Job Trends (6373)
News (167338)
Policy (12201)
Tag
Academia (1025)
Accelerated approval (5)
Adcomms (14)
Allergies (62)
Alliances (25606)
ALS (90)
Alzheimer's disease (991)
Antibody-drug conjugate (ADC) (131)
Approvals (6715)
Artificial intelligence (160)
Autoimmune disease (26)
Automation (8)
Bankruptcy (163)
Best Places to Work (5625)
BIOSECURE Act (8)
Biosimilars (65)
Biotechnology (237)
Bladder cancer (72)
Brain cancer (29)
Breast cancer (219)
Cancer (2025)
Cardiovascular disease (149)
Career advice (283)
Career pathing (2)
CAR-T (154)
CDC (6)
Cell therapy (412)
Cervical cancer (11)
Clinical research (44031)
Collaboration (747)
Company closure (1)
Compensation (367)
Complete response letters (19)
COVID-19 (1120)
CRISPR (63)
C-suite (250)
Cystic fibrosis (90)
Data (2282)
Denatured (13)
Depression (53)
Diabetes (188)
Diagnostics (1894)
Digital health (5)
Diversity (3)
Diversity, equity & inclusion (10)
Drug discovery (110)
Drug pricing (34)
Drug shortages (3)
Duchenne muscular dystrophy (142)
Earnings (34574)
Editorial (22)
Employer branding (6)
Employer resources (32)
Events (55935)
Executive appointments (603)
FDA (7756)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (685)
Gene editing (129)
Generative AI (10)
Gene therapy (339)
GLP-1 (428)
Government (1306)
Grass and pollen (2)
Guidances (103)
Healthcare (7960)
HIV (13)
Huntington's disease (29)
IgA nephropathy (38)
Immunology and inflammation (120)
Immuno-oncology (6)
Indications (25)
Infectious disease (1202)
Inflammatory bowel disease (129)
Inflation Reduction Act (9)
Influenza (28)
Intellectual property (91)
Interviews (39)
IPO (10076)
IRA (12)
Job creations (1049)
Job search strategy (255)
Kidney cancer (8)
Labor market (11)
Layoffs (230)
Leadership (4)
Legal (2160)
Liver cancer (36)
Longevity (8)
Lung cancer (277)
Lymphoma (147)
Machine learning (6)
Management (7)
Manufacturing (216)
MASH (81)
Medical device (4204)
Medtech (4205)
Mergers & acquisitions (8948)
Metabolic disorders (510)
Multiple sclerosis (72)
NASH (13)
Neurodegenerative disease (105)
Neuropsychiatric disorders (32)
Neuroscience (1556)
NextGen: Class of 2025 (2757)
Non-profit (1086)
Now hiring (24)
Obesity (238)
Opinion (110)
Ovarian cancer (88)
Pain (64)
Pancreatic cancer (94)
Parkinson's disease (158)
Partnered (11)
Patents (204)
Patient recruitment (129)
Peanut (40)
People (29672)
Pharmaceutical (47)
Pharmacy benefit managers (6)
Phase I (15363)
Phase II (20372)
Phase III (13144)
Pipeline (1211)
Policy (71)
Postmarket research (945)
Preclinical (6472)
Press Release (31)
Prostate cancer (92)
Psychedelics (42)
Radiopharmaceuticals (228)
Rare diseases (385)
Real estate (1905)
Recruiting (13)
Regulatory (10227)
Reports (22)
Research institute (1062)
Resumes & cover letters (35)
Rett syndrome (8)
RNA editing (12)
RSV (15)
Schizophrenia (80)
Series A (126)
Series B (88)
Service/supplier (1)
Sickle cell disease (52)
Special edition (13)
Spinal muscular atrophy (119)
Sponsored (13)
Startups (2246)
State (2)
Stomach cancer (6)
Supply chain (32)
Tariffs (15)
The Weekly (45)
Vaccines (283)
Venture capital (41)
Weight loss (119)
Women's health (18)
Worklife (2)
Date
Today (79)
Last 7 days (323)
Last 30 days (1098)
Last 365 days (20161)
2025 (11564)
2024 (22580)
2023 (24928)
2022 (30380)
2021 (31998)
2020 (27626)
2019 (20243)
2018 (14875)
2017 (16284)
2016 (14087)
2015 (17415)
2014 (12560)
2013 (9380)
2012 (9579)
2011 (9513)
2010 (9024)
Location
Africa (182)
Alabama (53)
Alaska (2)
Arizona (79)
Arkansas (5)
Asia (19970)
Australia (3275)
California (5220)
Canada (1446)
China (511)
Colorado (192)
Connecticut (197)
Delaware (145)
Europe (41143)
Florida (700)
Georgia (167)
Hawaii (2)
Idaho (24)
Illinois (337)
India (13)
Indiana (170)
Iowa (8)
Japan (134)
Kansas (71)
Kentucky (10)
Louisiana (5)
Maine (49)
Maryland (626)
Massachusetts (4111)
Michigan (144)
Minnesota (204)
Mississippi (4)
Missouri (38)
Montana (16)
Nebraska (7)
Nevada (48)
New Hampshire (27)
New Jersey (1333)
New Mexico (13)
New York (1389)
North Carolina (799)
North Dakota (6)
Northern California (2317)
Ohio (149)
Oklahoma (9)
Oregon (22)
Pennsylvania (1010)
Puerto Rico (7)
Rhode Island (22)
South America (271)
South Carolina (11)
South Dakota (1)
Southern California (2003)
Tennessee (47)
Texas (714)
United States (18288)
Utah (96)
Virginia (119)
Washington D.C. (37)
Washington State (443)
West Virginia (3)
Wisconsin (29)
321,462 Results for "century therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
May 29, 2025
·
5 min read
Press Releases
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
·
12 min read
Press Releases
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
·
5 min read
Press Releases
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 20, 2025
·
13 min read
Press Releases
ITF Therapeutics LLC to Present Patient-Reported Outcome Data for DUVYZAT® (givinostat) in Duchenne Muscular Dystrophy at ISPOR 2025
May 15, 2025
·
7 min read
Press Releases
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
April 15, 2025
·
5 min read
Press Releases
MANAMED® LLC Achieves ISO 13485 Certification, Reinforcing Commitment to Quality and Global Expansion
July 3, 2025
·
2 min read
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
Press Releases
Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
June 18, 2025
·
5 min read
Business
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune diseases, today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 9, 2024
·
13 min read
1 of 32,147
Next
